Day: December 16, 2020

16 December 2020Announcement no. 314Refinancing of loanReferring to Company Announcement no. 311 of 16 November 2020, in which it was stated that Rovsing A/S shall refinance a loan of DKK 4.200.000 no later than 31 December 2020. The Company can hereby announce that it has made an agreement with a consortium of 6 lenders for a new loan. Once the new lenders have deposited the funds to Rovsing A/S account, the old loan will be repaid, no later than the 31 of December.The new loan is with the following termsA loan of DKK 4.200.000 with a term of 36 months12% annual interest with quarterly accrual of interestThe loan is non-cancellable for the lender while the borrower is free to repay the loan with 1 weeks’ noticeWhen the borrower repays the loan, the lender can choose either to be repaid at a price of 108 in cash or to convert the loan...

Lucky Dino generated $21M revenue and $3.8M EBITDA in FY20 and is forecasted to grow to $29M revenue and $6.5M EBITDA in FY22Cross-sell opportunities with 30K monthly active playersNEWARK, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) — Esports Entertainment Group, Inc. (NasdaqCM: GMBL, GMBLW) (or the “Company”), an esports entertainment and online gambling operator, today announced that its Malta gaming licensed subsidiary, Esports Entertainment (Malta) Limited, has signed an asset purchase agreement to acquire the business of Lucky Dino Gaming Limited (“Lucky Dino”), an established Malta licensed online casino operator with its own proprietary casino platform. The estimated $30 million deal (Eur25m) is expected to be financed through a debt facility procured by the Company.“Over the past five years, Lucky Dino has evolved from a...

– Company invests to build in-house capabilities to support advancement of pipeline –– In combination with dedicated CGMP suite at Catalent, the new laboratory creates foundation for integrated AAV gene therapy manufacturing –PHILADELPHIA, Dec. 16, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, today announced that it has entered into a long-term lease to support Chemistry, Manufacturing and Controls (CMC) laboratory operations for the company’s gene therapy programs. The new laboratory, slated to open in the second quarter of 2021 at the Princeton West Innovation Campus in Hopewell, New Jersey, will initially focus on state-of-the-art analytical capabilities, clinical...

ROSELAND, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today reported that the Company’s Interim CEO, Leonard Osser, plans to exercise up to 336,970 options. In connection with the transaction, he plans to sell a portion of his shares to cover the cost of the options and associated taxes. However, the net impact of the transaction will be an increase in Mr. Osser’s overall common stock holdings. Mr. Osser has no plans to sell additional shares.About Milestone Scientific Inc.Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments...

JACKSONVILLE, Fla., Dec. 16, 2020 (GLOBE NEWSWIRE) — Regency Centers Corporation (The “Company”) (NASDAQ: REG) will announce its Fourth Quarter 2020 earnings results on Thursday, February 11, 2021, after the market closes. The Company’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website – investors.regencycenters.com. The Company will host an earnings conference call on Friday, February 12, 2021, at 12:00 p.m. ET.ReplayWebcast Archive: Investor Relations page under Webcasts & PresentationsAbout Regency Centers Corporation (NASDAQ: REG)Regency Centers is the preeminent national owner, operator, and developer of shopping centers located in affluent and densely populated trade areas. Operating as a fully integrated real estate company, Regency Centers...

QUEBEC CITY, Dec. 16, 2020 (GLOBE NEWSWIRE) — (TSXV: HEO) – H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) is proud to announce its business line Piedmont, a global leader in corrosion resistant equipment for desalination plants in the industrial and municipal markets, secured three large orders for fiber reinforced polyester (“FRP”) cartridge filter housings and duplex stainless couplings, totalling $3.3 M. The team also signed two new distribution agreements in new geographies.Over the last few months, Piedmont has received several new contracts for the supply of FRP cartridge filter housings, cartridge filtration elements as well as flexible couplings of small to medium sizes. Today, the contracted scope is for three new large-scale seawater reverse osmosis (“RO”) desalination plants. Two of these desalination plants...

QUÉBEC, 16 déc. 2020 (GLOBE NEWSWIRE) — (TSXV : HEO) – H2O Innovation inc. (« H2O Innovation » ou la « Société ») est fière d’annoncer aujourd’hui que sa ligne d’affaires Piedmont, leader mondial dans l’équipement anticorrosif pour les usines de dessalement d’eau de mer pour les marchés industriels et municipaux, a remporté trois importants contrats de filtres à cartouches renforcés de fibres de verre (« FRP ») et de raccords duplex en acier inoxydable, totalisant 3,3 M $. L’équipe a également signé deux nouveaux accords de distribution dans de nouvelles zones géographiques.Au cours des derniers mois, Piedmont a reçu plusieurs nouveaux contrats pour la fourniture de filtres à cartouches faits de FRP, d’éléments de filtres à cartouches ainsi que de raccords flexibles de petites et de moyennes tailles. Aujourd’hui,...

COMPANY ANNOUNCEMENTNo. 71/2020Tvis, 16 December 2020Financial calendar 2021The Board of Directors of TCM Group A/S has set the following dates for publication of the interim reports, annual reports and annual general meeting:24 February 2021                               Interim report Q4 2020 and Annual report 20202 March 2021                                     Deadline for submission of shareholder proposals to Annual General Meeting13 April 2021                                      Annual General Meeting19 May 2021                                      Interim report Q1 202120 August 2021                                  Interim report Q2 202112 November 2021                             Interim report Q3 202125 February 2022                               Interim report Q4 2021 and Annual report 20215 April 2022                   ...